Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Azria

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Calcified Tissue International|January 1, 1993
Lack of effect of ipriflavone on osteoclast motility and bone resorption in in vitro and ex vivo studiesM Azria, C Behhar, S Cooper
Molecular and Cellular Endocrinology|December 1, 1983
Quantitative cytochemical responses to exogenously administered calcitonins in rat kidney and bone cellsD M Salmon, M Azria, J M Zanelli
Bone|November 26, 1999
Effects of calcitonin on animal and in vitro models of skeletal metabolismS Wallach, G Rousseau, L Martin, et al.
Acta Endocrinologica|April 1, 1985
Decreased responsiveness to chronic salmon calcitonin treatment in rat kidney and calvaria studied using quantitative enzyme cytochemistryD M Salmon, M Azria, J M Zanelli
Journal of Pharmacological Methods|January 1, 1982
Flow measurement of blood radioactivity in animalsF Simonnet, M Azria, M Bourdinaud, et al.
Calcified Tissue International|December 1, 1995
25 years of salmon calcitonin: from synthesis to therapeutic useM Azria, D H Copp, J M Zanelli
The American Journal of Medicine|April 1, 1987
Effectiveness of salmon calcitonin administered as suppositories in tumor-induced hypercalcemiaD Thiébaud, P Burckhardt, P Jaeger, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 9, 2015
Nasal salmon calcitonin blunts bone microstructure alterations in healthy postmenopausal womenR Rizzoli, A Sigaud, M Azria, et al.
Annales Pharmaceutiques Francaises|March 1, 1972
[Study of the microbial contamination of pharmaceutical syrups]S Lambin, A Desvignes, J L Kiger, et al.
Journal of Musculoskeletal & Neuronal Interactions|September 21, 2005
Rationale for the potential use of calcitonin in osteoarthritisD H Manicourt, J P Devogelaer, M Azria, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Calcified Tissue International|January 1, 1993
Lack of effect of ipriflavone on osteoclast motility and bone resorption in in vitro and ex vivo studiesM Azria, C Behhar, S Cooper
Molecular and Cellular Endocrinology|December 1, 1983
Quantitative cytochemical responses to exogenously administered calcitonins in rat kidney and bone cellsD M Salmon, M Azria, J M Zanelli
Bone|November 26, 1999
Effects of calcitonin on animal and in vitro models of skeletal metabolismS Wallach, G Rousseau, L Martin, et al.
Acta Endocrinologica|April 1, 1985
Decreased responsiveness to chronic salmon calcitonin treatment in rat kidney and calvaria studied using quantitative enzyme cytochemistryD M Salmon, M Azria, J M Zanelli
Journal of Pharmacological Methods|January 1, 1982
Flow measurement of blood radioactivity in animalsF Simonnet, M Azria, M Bourdinaud, et al.
Calcified Tissue International|December 1, 1995
25 years of salmon calcitonin: from synthesis to therapeutic useM Azria, D H Copp, J M Zanelli
The American Journal of Medicine|April 1, 1987
Effectiveness of salmon calcitonin administered as suppositories in tumor-induced hypercalcemiaD Thiébaud, P Burckhardt, P Jaeger, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 9, 2015
Nasal salmon calcitonin blunts bone microstructure alterations in healthy postmenopausal womenR Rizzoli, A Sigaud, M Azria, et al.
Annales Pharmaceutiques Francaises|March 1, 1972
[Study of the microbial contamination of pharmaceutical syrups]S Lambin, A Desvignes, J L Kiger, et al.
Journal of Musculoskeletal & Neuronal Interactions|September 21, 2005
Rationale for the potential use of calcitonin in osteoarthritisD H Manicourt, J P Devogelaer, M Azria, et al.
Pageof 3